文献速递MDS 与骨髓增殖性肿瘤白血病

小鼠双微体2和4蛋白(而非信使RNA)表达降低与骨髓增生异常综合征及急性髓细胞白血病更严重疾病相关

Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.
PubMed 文献 · Br J Haematol · 2022-12-22

研究检测111例急性髓细胞白血病、骨髓增生异常综合征或慢性粒单核细胞白血病患者骨髓样本中MDM2、MDM4和TP53的蛋白(流式细胞术)及mRNA(定量PCR)表达。骨髓原始细胞>5%的患者未成熟细胞中MDM2和MDM4蛋白表达低于健康供者及原始细胞<5%的患者,而mRNA水平在所有样本中无差别。低MDM2和MDM4蛋白表达与较差生存相关。

要点

  • 骨髓原始细胞>5%患者未成熟细胞MDM2和MDM4蛋白表达低于健康供者及原始细胞<5%患者。
  • 所有样本中MDM2和MDM4的mRNA水平无论疾病状态或原始细胞水平均无差别。
  • 低MDM2和MDM4蛋白表达与较差生存相关。

核心结论

  • 晚期疾病与MDM2和MDM4蛋白表达降低相关,提示MDM2和MDM4抑制剂在晚期髓系恶性肿瘤治疗中的效用可能需重新考虑。

研究设计与样本

  • 检查111例急性髓细胞白血病、骨髓增生异常综合征或慢性粒单核细胞白血病患者骨髓样本中MDM2、MDM4和TP53的蛋白(荧光激活细胞分选)及mRNA(定量聚合酶链反应)表达。

主要发现

  • 骨髓原始细胞>5%的患者未成熟细胞中MDM2和MDM4蛋白表达低于健康供者CD34+/CD45low细胞及原始细胞<5%的患者。
  • 所有样本中mRNA水平无论疾病状态或原始细胞水平均无差别。
  • 低MDM2和MDM4蛋白表达与较差生存相关。
  • mRNA与蛋白表达水平相关性差,提示应采用定量流式细胞术分析蛋白表达水平来预测和验证MDM2和MDM4抑制剂的疗效。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The human homologues of murine double minute 2 (MDM2) and 4 (MDM4) negatively regulate p53 tumour suppressor activity and are reported to be frequently overexpressed in human malignancies, prompting clinical trials with drugs that prevent interactions between MDM2/MDM4 and p53. Bone marrow samples from 111 patients with acute myeloblastic leukaemia, myelodysplastic syndrome or chronic myelomonocytic leukaemia were examined for protein (fluorescence-activated cell sorting) and messenger RNA (mRNA) expression (quantitative polymerase chain reaction) of MDM2, MDM4 and tumour protein p53 (TP53). Low protein expression of MDM2 and MDM4 was observed in immature cells from patients with excess of marrow blasts (>5%) compared with CD34+ /CD45low cells from healthy donors and patients without excess of marrow blasts (<5%). The mRNA levels were indistinguishable in all samples examined regardless of disease status or blast levels. Low MDM2 and MDM4 protein expression were correlated with poor survival. These data show a poor correlation between mRNA and protein expression levels, suggesting that quantitative flow cytometry analysis of protein expression levels should be used to predict and validate the efficacy of MDM2 and MDM4 inhibitors. These findings show that advanced disease is associated with reduced MDM2 and MDM4 protein expression and indicate that the utility of MDM2 and MDM4 inhibitors may have to be reconsidered in the treatment of advanced myeloid malignancies.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Salomao N, Maslah N, Giulianelli A, et al. Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia. Br J Haematol. 2022. PMID: 36546586. doi:10.1111/bjh.18608

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。